agilon health, inc. files Definitive Proxy Statement

Ticker: AGL · Form: DEF 14A · Filed: Apr 18, 2024 · CIK: 1831097

Agilon Health, Inc. DEF 14A Filing Summary
FieldDetail
CompanyAgilon Health, Inc. (AGL)
Form TypeDEF 14A
Filed DateApr 18, 2024
Risk Level
Pages15
Reading Time18 min
Key Dollar Amounts$200 million, $0.01
Sentimentneutral

Sentiment: neutral

Topics: proxy statement, agilon health, Medicare Advantage, healthcare, financial performance

TL;DR

<b>agilon health, inc. filed its Definitive Proxy Statement, detailing 2023 achievements and strategies to address industry transition challenges.</b>

AI Summary

agilon health, inc. (AGL) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. agilon health, inc. filed a Definitive Proxy Statement (DEF 14A) on April 18, 2024. The filing covers the period ending May 29, 2024. The company established new partnerships with physician practices and health systems in 2023. agilon expanded its Physician Network and enhanced its platform in 2023. The company is navigating a complex transition period in the Medicare Advantage sector due to increased utilization costs among the senior population.

Why It Matters

For investors and stakeholders tracking agilon health, inc., this filing contains several important signals. The filing provides shareholders with information regarding the company's governance and strategic direction, particularly in light of recent industry cost pressures. Shareholders can review the company's response to increased utilization costs in the Medicare Advantage sector and its plans for future performance normalization.

Risk Assessment

Risk Level: — agilon health, inc. shows moderate risk based on this filing. The company faces medium risk due to increased utilization costs in the Medicare Advantage sector, which are impacting margins and requiring significant reserve strengthening and guidance resets.

Analyst Insight

Shareholders should closely monitor agilon health's execution of its January 2024 action plan focused on operational improvements and its ability to return to a normalized margin trajectory.

Key Numbers

  • 1,000+ — Employees (Number of employees at agilon health)

Key Players & Entities

  • agilon health, inc. (company) — Filer of the proxy statement
  • Centers for Medicare & Medicaid Services (CMS) (regulator) — Benchmarks and payor bids are influenced by CMS
  • 2023 (date) — Year of reported achievements and reserve strengthening
  • 2024 (date) — Year for reset guidance and action plan implementation
  • January 2024 (date) — Month the action plan was outlined
  • April 18, 2024 (date) — Filing date of the proxy statement
  • May 29, 2024 (date) — Conformed period of report

FAQ

When did agilon health, inc. file this DEF 14A?

agilon health, inc. filed this Proxy Statement (DEF 14A) with the SEC on April 18, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by agilon health, inc. (AGL).

Where can I read the original DEF 14A filing from agilon health, inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by agilon health, inc..

What are the key takeaways from agilon health, inc.'s DEF 14A?

agilon health, inc. filed this DEF 14A on April 18, 2024. Key takeaways: agilon health, inc. filed a Definitive Proxy Statement (DEF 14A) on April 18, 2024.. The filing covers the period ending May 29, 2024.. The company established new partnerships with physician practices and health systems in 2023..

Is agilon health, inc. a risky investment based on this filing?

Based on this DEF 14A, agilon health, inc. presents a moderate-risk profile. The company faces medium risk due to increased utilization costs in the Medicare Advantage sector, which are impacting margins and requiring significant reserve strengthening and guidance resets.

What should investors do after reading agilon health, inc.'s DEF 14A?

Shareholders should closely monitor agilon health's execution of its January 2024 action plan focused on operational improvements and its ability to return to a normalized margin trajectory. The overall sentiment from this filing is neutral.

How does agilon health, inc. compare to its industry peers?

agilon health operates within the Medicare Advantage sector, providing services to community-based physicians to manage care for older adults.

Are there regulatory concerns for agilon health, inc.?

The company's operations are subject to regulations set by the Centers for Medicare & Medicaid Services (CMS), which influence reimbursement rates and industry benchmarks.

Risk Factors

  • Increased Utilization Costs [medium — financial]: Costs among the senior population rose faster than contemplated in CMS benchmarks and payor bids due to increased utilization, impacting margins.

Industry Context

agilon health operates within the Medicare Advantage sector, providing services to community-based physicians to manage care for older adults.

Regulatory Implications

The company's operations are subject to regulations set by the Centers for Medicare & Medicaid Services (CMS), which influence reimbursement rates and industry benchmarks.

What Investors Should Do

  1. Review the detailed financial performance and outlook presented in the proxy statement.
  2. Assess the company's strategic initiatives and action plan to mitigate the impact of increased utilization costs.
  3. Evaluate the management's commentary on the industry transition and its expected impact on future margins.

Key Dates

  • 2024-04-18: Filing of Definitive Proxy Statement (DEF 14A) — Provides shareholders with updated information on company strategy and performance.

Glossary

Medicare Advantage
A type of Medicare health plan offered by private companies approved by Medicare. (The sector agilon health operates in and is experiencing cost transition challenges.)
CMS
Centers for Medicare & Medicaid Services (Sets benchmarks and influences payor bids relevant to agilon's business.)

Year-Over-Year Comparison

This filing is a Definitive Proxy Statement (DEF 14A), which typically follows preliminary filings and provides detailed information for shareholder meetings and voting.

Filing Stats: 4,622 words · 18 min read · ~15 pages · Grade level 14.9 · Accepted 2024-04-18 17:07:22

Key Financial Figures

  • $200 million — ging environment, reinvesting more than $200 million last year. We now have 31 partners in 1
  • $0.01 — lding shares of common stock, par value $0.01 per share (the "Shares") as of the clos

Filing Documents

Executive Compensation

Executive Compensation 54

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 57 Certain Relationships and Related Party Transactions 59 Proposal 1: Election of Directors 60 Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm 62 Proposal 3: Advisory Vote to Approve Executive Compensation 63 Other Business 64 Website References TABLE OF CONTENTS Cautionary Language Regarding Forward-Looking Statements .

EXECUTIVE COMPENSATION PROGRAM DESIGN AND GOVERNANCE PRACTICES

EXECUTIVE COMPENSATION PROGRAM DESIGN AND GOVERNANCE PRACTICES Our executive compensation program is designed to provide strong alignment between executive pay, stockholder interests, and company performance, and incorporates best practices such as the following: WHAT WE DO Reward our executives commensurate with their performance, experience and capabilities Reward achievement of short-term business objectives and results Align executive and stockholder interests Create "ownership culture" with equity awards Provide employment retention incentives Provide competitive employee benefits Reward achievement of goals related to our team and culture engagement plan, leadership development and our diversity, equity, inclusion and belonging priorities Emphasize long-term growth through maximizing focus on increasing shareholder value WHAT WE DON'T DO No hedging or monetization transactions with respect to the Company's securities No pledging of the Company's securities as collateral for a loan No compensation practices that encourage unnecessary and excessive risk taking Do not provide dividends or dividend equivalents on unearned PSUs unless and until the underlying PSU vests (and if such PSUs are forfeited, no dividend equivalents are paid out) Do not grant stock options or stock appreciation rights with an exercise price less than the fair market value on the grant date agilon health 2024 Proxy Statement | 3 TABLE OF CONTENTS Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be Held on May 29, 2024 . The proxy statement and annual report to stockholders are available at www.proxyvote.com or www.investors.agilonhealth.com In accordance with rules and regulations adopted by the SEC, we are pleased to provide access to our proxy materials over the Internet to all of our stockholders rather than in paper form. Accordingly, a Notice of Internet Availability of Proxy Materials (the "

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.